Phase 3 Pancreatitis Trial, Recruiting (NCT02000089)

Phase 3 Pancreatitis Trial, Recruiting NCT02000089 Sponsor: Johns Hopkins University Condition: Pancreatitis

Printed from Voxsanity (voxsanity.com.au) — NCT02000089 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Hereditary Pancreatitis
You have been diagnosed with Peutz-Jeghers Syndrome (a condition that causes growths in the digestive tract and increases cancer risk)
You have a strong history of pancreatic cancer on one side of your family (either your mother's or father's side)
You have been confirmed to carry a genetic mutation linked to increased cancer risk, such as BRCA2, BRCA1, PALB2, ATM, CDKN2A/p16, or mutations associated with Lynch Syndrome, among others (confirm with trial site for the full list)
You already have a camera examination of your pancreas (called an endoscopy) scheduled

Who may not be able to join:

You have other health conditions or blood clotting problems that make having an endoscopy unsafe
You have had previous stomach surgery (such as partial or full stomach removal) that would make the examination difficult to perform
You have a narrowing or blockage in your upper digestive tract that would prevent the examination tool from passing through
You are in poor overall physical health (confirm with trial site on how this is assessed)
You are unable to give your own consent to take part in the trial
You are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT02000089

Sponsor: Johns Hopkins University

Phase: Phase 3

Status: Recruiting

Condition: Pancreatitis

More information: https://clinicaltrials.gov/study/NCT02000089

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Hereditary Pancreatitis
You have been diagnosed with Peutz-Jeghers Syndrome (a condition that causes growths in the digestive tract and increases cancer risk)
You have a strong history of pancreatic cancer on one side of your family (either your mother's or father's side)
You have been confirmed to carry a genetic mutation linked to increased cancer risk, such as BRCA2, BRCA1, PALB2, ATM, CDKN2A/p16, or mutations associated with Lynch Syndrome, among others (confirm with trial site for the full list)
You already have a camera examination of your pancreas (called an endoscopy) scheduled

Who may not be able to join:

You have other health conditions or blood clotting problems that make having an endoscopy unsafe
You have had previous stomach surgery (such as partial or full stomach removal) that would make the examination difficult to perform
You have a narrowing or blockage in your upper digestive tract that would prevent the examination tool from passing through
You are in poor overall physical health (confirm with trial site on how this is assessed)
You are unable to give your own consent to take part in the trial
You are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 3

Sponsor

Johns Hopkins University

Registry

ClinicalTrials.gov

Start date

6 January 2014

Est. completion

1 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Evaluate pancreatic juice for early cancer markers.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov